News Gilead's next gen HIV prevention trial to begin in UK UK hospital seeking ethical clearance for trial of Gilead's new PReP drug.
News NICE review sparks new call for HIV prophylaxis NICE review backs case for Truvada pre-exposure prophylaxis, say campaigners.
News Charity raises funds for legal fight over HIV drug National AIDS Trust continues legal battle over Truvada.
Views & Analysis Pre-exposure treatment to help prevent HIV Wider use of Pre-Exposure Prophylaxis (PrEP), where people who don't have HIV take a pill every day, could prevent around 7,400 new HIV infections in the UK by 2020.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.